{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T03:50:59Z","timestamp":1790221859848,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,8,16]],"date-time":"2018-08-16T00:00:00Z","timestamp":1534377600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Fujian Kangshimei Co"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s13346-018-0570-0","type":"journal-article","created":{"date-parts":[[2018,8,16]],"date-time":"2018-08-16T13:51:56Z","timestamp":1534427516000},"page":"1406-1420","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Curcumin-loaded self-nanomicellizing solid dispersion system: part II: in vivo safety and efficacy assessment against behavior deficit in Alzheimer disease"],"prefix":"10.1007","volume":"8","author":[{"given":"Ankit","family":"Parikh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna","family":"Kathawala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jintao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengnan","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Fu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,16]]},"reference":[{"issue":"5800","key":"570_CR1","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1126\/science.1132813","volume":"314","author":"ED Roberson","year":"2006","unstructured":"Roberson ED, Mucke L. 100\u00a0years and counting: prospects for defeating Alzheimer\u2019s disease. Science. 2006;314(5800):781\u20134. \n                    https:\/\/doi.org\/10.1126\/science.1132813\n                    \n                  .","journal-title":"Science"},{"issue":"7","key":"570_CR2","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/S1474-4422(10)70119-8","volume":"9","author":"F Mangialasche","year":"2010","unstructured":"Mangialasche F, Solomon A, Winblad B, Mecocci P, Kivipelto M. Alzheimer\u2019s disease: clinical trials and drug development. The Lancet Neurology. 2010;9(7):702\u201316. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(10)70119-8\n                    \n                  .","journal-title":"The Lancet Neurology"},{"key":"570_CR3","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.bcp.2014.01.002","volume":"88","author":"K Iqbal","year":"2014","unstructured":"Iqbal K, Liu F, Gong CX. Alzheimer disease therapeutics: focus on the disease and not just plaques and tangles. Biochem Pharmacol. 2014;88:631\u20139. \n                    https:\/\/doi.org\/10.1016\/j.bcp.2014.01.002\n                    \n                  .","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"570_CR4","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/joim.12191","volume":"275","author":"LS Schneider","year":"2014","unstructured":"Schneider LS, Mangialasche F, Andreasen N, Feldman H, Giacobini E, Jones R, et al. Clinical trials and late-stage drug development for Alzheimer\u2019s disease: an appraisal from 1984 to 2014. J Intern Med. 2014;275(3):251\u201383. \n                    https:\/\/doi.org\/10.1111\/joim.12191\n                    \n                  .","journal-title":"J Intern Med"},{"issue":"1","key":"570_CR5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.4103\/0972-2327.40220","volume":"11","author":"S Mishra","year":"2008","unstructured":"Mishra S, Palanivelu K. The effect of curcumin (turmeric) on Alzheimer\u2019s disease: an overview. Annals of Indian Academy of Neurology. 2008;11(1):13\u20139. \n                    https:\/\/doi.org\/10.4103\/0972-2327.40220\n                    \n                  .","journal-title":"Annals of Indian Academy of Neurology"},{"key":"570_CR6","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3389\/fneur.2014.00069","volume":"5","author":"YQ Zeng","year":"2014","unstructured":"Zeng YQ, Wang YJ, Zhou XF. Effects of (\u2212)epicatechin on the pathology of APP\/PS1 transgenic mice. Front Neurol. 2014;5:69. \n                    https:\/\/doi.org\/10.3389\/fneur.2014.00069\n                    \n                  .","journal-title":"Front Neurol"},{"issue":"1","key":"570_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12640-009-9000-x","volume":"15","author":"YJ Wang","year":"2009","unstructured":"Wang YJ, Thomas P, Zhong JH, Bi FF, Kosaraju S, Pollard A, et al. Consumption of grape seed extract prevents amyloid-beta deposition and attenuates inflammation in brain of an Alzheimer\u2019s disease mouse. Neurotox Res. 2009;15(1):3\u201314. \n                    https:\/\/doi.org\/10.1007\/s12640-009-9000-x\n                    \n                  .","journal-title":"Neurotox Res"},{"issue":"5","key":"570_CR8","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/alzrt146","volume":"4","author":"JM Ringman","year":"2012","unstructured":"Ringman JM, Frautschy SA, Teng E, Begum AN, Bardens J, Beigi M, et al. Oral curcumin for Alzheimer\u2019s disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study. Alzheimers Res Ther. 2012;4(5):43. \n                    https:\/\/doi.org\/10.1186\/alzrt146\n                    \n                  .","journal-title":"Alzheimers Res Ther"},{"issue":"5","key":"570_CR9","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.bbadis.2011.10.006","volume":"1822","author":"P Mecocci","year":"2012","unstructured":"Mecocci P, Polidori MC. Antioxidant clinical trials in mild cognitive impairment and Alzheimer\u2019s disease. Biochim Biophys Acta. 2012;1822(5):631\u20138. \n                    https:\/\/doi.org\/10.1016\/j.bbadis.2011.10.006\n                    \n                  .","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"570_CR10","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1021\/mp700113r","volume":"4","author":"P Anand","year":"2007","unstructured":"Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: problems and promises. Mol Pharm. 2007;4(6):807\u201318. \n                    https:\/\/doi.org\/10.1021\/mp700113r\n                    \n                  .","journal-title":"Mol Pharm"},{"issue":"1\u20132","key":"570_CR11","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.ijpharm.2016.10.052","volume":"515","author":"A Parikh","year":"2016","unstructured":"Parikh A, Kathawala K, Tan CC, Garg S, Zhou XF. Development of a novel oral delivery system of edaravone for enhancing bioavailability. Int J Pharm. 2016;515(1\u20132):490\u2013500. \n                    https:\/\/doi.org\/10.1016\/j.ijpharm.2016.10.052\n                    \n                  .","journal-title":"Int J Pharm"},{"issue":"1","key":"570_CR12","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1080\/10717544.2017.1337825","volume":"24","author":"A Parikh","year":"2017","unstructured":"Parikh A, Kathawala K, Tan CC, Garg S, Zhou XF. Lipid-based nanosystem of edaravone: development, optimization, characterization and in vitro\/in vivo evaluation. Drug delivery. 2017;24(1):962\u201378. \n                    https:\/\/doi.org\/10.1080\/10717544.2017.1337825\n                    \n                  .","journal-title":"Drug delivery"},{"key":"570_CR13","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.2147\/DDDT.S161940","volume":"12","author":"A Parikh","year":"2018","unstructured":"Parikh A, Kathawala K, Tan CC, Garg S, Zhou X-F. Self-nanomicellizing solid dispersion of edaravone: part I; oral bioavailability improvement. Drug design, development and therapy. 2018;12:2051\u201369. \n                    https:\/\/doi.org\/10.2147\/dddt.s161940\n                    \n                  .","journal-title":"Drug design, development and therapy"},{"key":"570_CR14","doi-asserted-by":"publisher","unstructured":"Parikh A, Kathawala K, Song Y, Zhou XF, Garg S. Curcumin-loaded self-nanomicellizing solid dispersion system: part I: development, optimization, characterization, and oral bioavailability. Drug delivery and translational research. 2018; \n                    https:\/\/doi.org\/10.1007\/s13346-018-0543-3\n                    \n                  .","DOI":"10.1007\/s13346-018-0543-3"},{"key":"570_CR15","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.2147\/DDDT.S161944","volume":"12","author":"A Parikh","year":"2018","unstructured":"Parikh A, Kathawala K, Li J, Chen C, Shan Z, Cao X, et al. Self-nanomicellizing solid dispersion of edaravone: part II: in vivo assessment of efficacy against behavior deficits and safety in Alzheimer\u2019s disease model. Drug design, development and therapy. 2018;12:2111\u201328. \n                    https:\/\/doi.org\/10.2147\/dddt.s161944\n                    \n                  .","journal-title":"Drug design, development and therapy"},{"issue":"2","key":"570_CR16","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1208\/s12249-015-0337-6","volume":"17","author":"CC Teixeira","year":"2016","unstructured":"Teixeira CC, Mendonca LM, Bergamaschi MM, Queiroz RH, Souza GE, Antunes LM, et al. Microparticles containing curcumin solid dispersion: stability. Bioavailability and anti-inflammatory activity AAPS pharmSciTech. 2016;17(2):252\u201361. \n                    https:\/\/doi.org\/10.1208\/s12249-015-0337-6\n                    \n                  .","journal-title":"Bioavailability and anti-inflammatory activity AAPS pharmSciTech"},{"issue":"1","key":"570_CR17","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1186\/s11671-015-1146-2","volume":"10","author":"C Wang","year":"2015","unstructured":"Wang C, Ma C, Wu Z, Liang H, Yan P, Song J, et al. Enhanced bioavailability and anticancer effect of curcumin-loaded electrospun nanofiber: in vitro and in vivo study. Nanoscale Res Lett. 2015;10(1):439. \n                    https:\/\/doi.org\/10.1186\/s11671-015-1146-2\n                    \n                  .","journal-title":"Nanoscale Res Lett"},{"issue":"12","key":"570_CR18","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.phymed.2015.08.006","volume":"22","author":"S Patil","year":"2015","unstructured":"Patil S, Choudhary B, Rathore A, Roy K, Mahadik K. Enhanced oral bioavailability and anticancer activity of novel curcumin loaded mixed micelles in human lung cancer cells. Phytomedicine : international journal of phytotherapy and phytopharmacology. 2015;22(12):1103\u201311. \n                    https:\/\/doi.org\/10.1016\/j.phymed.2015.08.006\n                    \n                  .","journal-title":"Phytomedicine : international journal of phytotherapy and phytopharmacology"},{"issue":"2","key":"570_CR19","first-page":"80","volume":"1","author":"S Hagl","year":"2014","unstructured":"Hagl S, Heinrich M, Kocher A, Schiborr C, Frank J, Eckert GP. Curcumin micelles improve mitochondrial function in a mouse model of Alzheimer\u2019s disease. The Journal of Prevention of Alzheimer\u2019s Disease. 2014;1(2):80\u20133.","journal-title":"The Journal of Prevention of Alzheimer\u2019s Disease"},{"issue":"1","key":"570_CR20","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/npp.2011.116","volume":"37","author":"NS Buckholtz","year":"2012","unstructured":"Buckholtz NS, Ryan LM, Petanceska S, Refolo LM. NIA commentary: translational issues in Alzheimer\u2019s disease drug development. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. 2012;37(1):284\u20136. \n                    https:\/\/doi.org\/10.1038\/npp.2011.116\n                    \n                  .","journal-title":"Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology"},{"key":"570_CR21","doi-asserted-by":"publisher","unstructured":"LaFerla FM, Green KN. Animal models of Alzheimer disease. Cold Spring Harbor perspectives in medicine. 2012; 2(11). \n                    https:\/\/doi.org\/10.1101\/cshperspect.a006320\n                    \n                  .","DOI":"10.1101\/cshperspect.a006320"},{"key":"570_CR22","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3389\/fphar.2013.00077","volume":"4","author":"C Saraceno","year":"2013","unstructured":"Saraceno C, Musardo S, Marcello E, Pelucchi S, Di Luca M. Modeling Alzheimer\u2019s disease: from past to future. Front Pharmacol. 2013;4:77. \n                    https:\/\/doi.org\/10.3389\/fphar.2013.00077\n                    \n                  .","journal-title":"Front Pharmacol"},{"issue":"1","key":"570_CR23","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/md14010005","volume":"14","author":"P Russo","year":"2015","unstructured":"Russo P, Kisialiou A, Lamonaca P, Moroni R, Prinzi G, Fini M. New drugs from marine organisms in Alzheimer\u2019s disease. Marine drugs. 2015;14(1):5. \n                    https:\/\/doi.org\/10.3390\/md14010005\n                    \n                  .","journal-title":"Marine drugs"},{"issue":"3","key":"570_CR24","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.neurobiolaging.2007.06.013","volume":"30","author":"YJ Wang","year":"2009","unstructured":"Wang YJ, Pollard A, Zhong JH, Dong XY, Wu XB, Zhou HD, et al. Intramuscular delivery of a single chain antibody gene reduces brain Abeta burden in a mouse model of Alzheimer\u2019s disease. Neurobiol Aging. 2009;30(3):364\u201376. \n                    https:\/\/doi.org\/10.1016\/j.neurobiolaging.2007.06.013\n                    \n                  .","journal-title":"Neurobiol Aging"},{"issue":"11","key":"570_CR25","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1038\/mp.2015.49","volume":"20","author":"XQ Yao","year":"2015","unstructured":"Yao XQ, Jiao SS, Saadipour K, Zeng F, Wang QH, Zhu C, et al. p75NTR ectodomain is a physiological neuroprotective molecule against amyloid-beta toxicity in the brain of Alzheimer\u2019s disease. Mol Psychiatry. 2015;20(11):1301\u201310. \n                    https:\/\/doi.org\/10.1038\/mp.2015.49\n                    \n                  .","journal-title":"Mol Psychiatry"},{"issue":"16","key":"570_CR26","doi-asserted-by":"publisher","first-page":"5225","DOI":"10.1073\/pnas.1422998112","volume":"112","author":"SS Jiao","year":"2015","unstructured":"Jiao SS, Yao XQ, Liu YH, Wang QH, Zeng F, Lu JJ, et al. Edaravone alleviates Alzheimer\u2019s disease-type pathologies and cognitive deficits. Proc Natl Acad Sci U S A. 2015;112(16):5225\u201330. \n                    https:\/\/doi.org\/10.1073\/pnas.1422998112\n                    \n                  .","journal-title":"Proc Natl Acad Sci U S A"},{"key":"570_CR27","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/srep00546","volume":"2","author":"DA Christakis","year":"2012","unstructured":"Christakis DA, Ramirez JS, Ramirez JM. Overstimulation of newborn mice leads to behavioral differences and deficits in cognitive performance. Sci Rep. 2012;2:546. \n                    https:\/\/doi.org\/10.1038\/srep00546\n                    \n                  .","journal-title":"Sci Rep"},{"key":"570_CR28","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.expneurol.2016.04.015","volume":"281","author":"CS Ruan","year":"2016","unstructured":"Ruan CS, Yang CR, Li JY, Luo HY, Bobrovskaya L, Zhou XF. Mice with Sort1 deficiency display normal cognition but elevated anxiety-like behavior. Exp Neurol. 2016;281:99\u2013108. \n                    https:\/\/doi.org\/10.1016\/j.expneurol.2016.04.015\n                    \n                  .","journal-title":"Exp Neurol"},{"issue":"7","key":"570_CR29","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1523\/JNEUROSCI.2528-15.2016","volume":"36","author":"Q Zhang","year":"2016","unstructured":"Zhang Q, Gao X, Li C, Feliciano C, Wang D, Zhou D, et al. Impaired dendritic development and memory in Sorbs2 knock-out mice. J Neurosci. 2016;36(7):2247\u201360. \n                    https:\/\/doi.org\/10.1523\/jneurosci.2528-15.2016\n                    \n                  .","journal-title":"J Neurosci"},{"key":"570_CR30","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.fct.2012.11.021","volume":"52","author":"B Bakoma","year":"2013","unstructured":"Bakoma B, Berke B, Eklu-Gadegbeku K, Agbonon A, Aklikokou K, Gbeassor M, et al. Acute and sub-chronic (28days) oral toxicity evaluation of hydroethanolic extract of Bridelia ferruginea Benth root bark in male rodent animals. Food Chem Toxicol. 2013;52:176\u20139. \n                    https:\/\/doi.org\/10.1016\/j.fct.2012.11.021\n                    \n                  .","journal-title":"Food Chem Toxicol"},{"issue":"3","key":"570_CR31","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.yrtph.2014.11.007","volume":"71","author":"Q Zhang","year":"2014","unstructured":"Zhang Q, Li J, Zhang W, An Q, Wen J, Wang A, et al. Acute and sub-chronic toxicity studies of honokiol microemulsion. Regul Toxicol Pharmacol. 2014;71(3):428\u201336. \n                    https:\/\/doi.org\/10.1016\/j.yrtph.2014.11.007\n                    \n                  .","journal-title":"Regul Toxicol Pharmacol"},{"issue":"Pt A","key":"570_CR32","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jep.2014.10.027","volume":"158","author":"L Wang","year":"2014","unstructured":"Wang L, Li Z, Li L, Li Y, Yu M, Zhou Y, et al. Acute and sub-chronic oral toxicity profiles of the aqueous extract of Cortex Dictamni in mice and rats. J Ethnopharmacol. 2014;158(Pt A):207\u201315. \n                    https:\/\/doi.org\/10.1016\/j.jep.2014.10.027\n                    \n                  .","journal-title":"J Ethnopharmacol"},{"issue":"9","key":"570_CR33","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1111\/j.1467-7652.2012.00730.x","volume":"10","author":"G Arjo","year":"2012","unstructured":"Arjo G, Capell T, Matias-Guiu X, Zhu C, Christou P, Pinol C. Mice fed on a diet enriched with genetically engineered multivitamin corn show no sub-acute toxic effects and no sub-chronic toxicity. Plant Biotechnol J. 2012;10(9):1026\u201334. \n                    https:\/\/doi.org\/10.1111\/j.1467-7652.2012.00730.x\n                    \n                  .","journal-title":"Plant Biotechnol J"},{"issue":"4","key":"570_CR34","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/0197-4580(93)90113-P","volume":"14","author":"MJ West","year":"1993","unstructured":"West MJ. Regionally specific loss of neurons in the aging human hippocampus. Neurobiol Aging. 1993;14(4):287\u201393.","journal-title":"Neurobiol Aging"},{"key":"570_CR35","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/S0006-8993(00)03186-3","volume":"891","author":"GW Arendash","year":"2001","unstructured":"Arendash GW, King DL, Gordon MN, Morgan D, Hatcher JM, Hope CE, et al. Progressive, age-related behavioral impairments in transgenic mice carrying both mutant amyloid precursor protein and presenilin-1 transgenes. Brain Res. 2001;891:42\u201353.","journal-title":"Brain Res"},{"issue":"2","key":"570_CR36","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.tips.2004.12.010","volume":"26","author":"PT Francis","year":"2005","unstructured":"Francis PT, Nordberg A, Arnold SE. A preclinical view of cholinesterase inhibitors in neuroprotection: do they provide more than symptomatic benefits in Alzheimer\u2019s disease? Trends Pharmacol Sci. 2005;26(2):104\u201311. \n                    https:\/\/doi.org\/10.1016\/j.tips.2004.12.010\n                    \n                  .","journal-title":"Trends Pharmacol Sci"},{"issue":"2","key":"570_CR37","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s10339-011-0430-z","volume":"13","author":"M Antunes","year":"2012","unstructured":"Antunes M, Biala G. The novel object recognition memory: neurobiology, test procedure, and its modifications. Cogn Process. 2012;13(2):93\u2013110. \n                    https:\/\/doi.org\/10.1007\/s10339-011-0430-z\n                    \n                  .","journal-title":"Cogn Process"},{"issue":"7630","key":"570_CR38","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/nature20127","volume":"539","author":"E Hebert-Chatelain","year":"2016","unstructured":"Hebert-Chatelain E, Desprez T, Serrat R, Bellocchio L, Soria-Gomez E, Busquets-Garcia A, et al. A cannabinoid link between mitochondria and memory. Nature. 2016;539(7630):555\u20139. \n                    https:\/\/doi.org\/10.1038\/nature20127\n                    \n                  .","journal-title":"Nature"},{"issue":"1","key":"570_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0147733","volume":"11","author":"A Wolf","year":"2016","unstructured":"Wolf A, Bauer B, Abner EL, Ashkenazy-Frolinger T, Hartz AM. A comprehensive behavioral test battery to assess learning and memory in 129S6\/Tg2576 mice. PLoS One. 2016;11(1):e0147733. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0147733\n                    \n                  .","journal-title":"PLoS One"},{"issue":"2","key":"570_CR40","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/nprot.2006.116","volume":"1","author":"CV Vorhees","year":"2006","unstructured":"Vorhees CV, Williams MT. Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat Protoc. 2006;1(2):848\u201358. \n                    https:\/\/doi.org\/10.1038\/nprot.2006.116\n                    \n                  .","journal-title":"Nat Protoc"},{"issue":"2","key":"570_CR41","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1002\/jnr.23322","volume":"92","author":"P Wang","year":"2014","unstructured":"Wang P, Su C, Li R, Wang H, Ren Y, Sun H, et al. Mechanisms and effects of curcumin on spatial learning and memory improvement in APPswe\/PS1dE9 mice. J Neurosci Res. 2014;92(2):218\u201331. \n                    https:\/\/doi.org\/10.1002\/jnr.23322\n                    \n                  .","journal-title":"J Neurosci Res"},{"issue":"1","key":"570_CR42","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1021\/nn405077y","volume":"8","author":"SK Tiwari","year":"2014","unstructured":"Tiwari SK, Agarwal S, Seth B, Yadav A, Nair S, Bhatnagar P, et al. Curcumin-loaded nanoparticles potently induce adult neurogenesis and reverse cognitive deficits in Alzheimer\u2019s disease model via canonical Wnt\/beta-catenin pathway. ACS Nano. 2014;8(1):76\u2013103. \n                    https:\/\/doi.org\/10.1021\/nn405077y\n                    \n                  .","journal-title":"ACS Nano"},{"issue":"4","key":"570_CR43","doi-asserted-by":"publisher","first-page":"221","DOI":"10.5483\/BMBRep.2012.45.4.221","volume":"45","author":"DC Kim","year":"2012","unstructured":"Kim DC, Ku SK, Bae JS. Anticoagulant activities of curcumin and its derivative. BMB Rep. 2012;45(4):221\u20136.","journal-title":"BMB Rep"},{"issue":"4","key":"570_CR44","doi-asserted-by":"publisher","first-page":"358","DOI":"10.18905\/shikaigaku.64.4_358","volume":"64","author":"IS Takashi Ikeo","year":"2001","unstructured":"Takashi Ikeo IS. Age-related changes in hematology and serum biochemistry values in SAMR1 and SAMP8 mice. Shikaigaku. 2001;64(4):358\u201368. \n                    https:\/\/doi.org\/10.18905\/shikaigaku.64.4_358\n                    \n                  .","journal-title":"Shikaigaku"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13346-018-0570-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-018-0570-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-018-0570-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,15]],"date-time":"2019-08-15T23:26:51Z","timestamp":1565911611000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13346-018-0570-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,16]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["570"],"URL":"https:\/\/doi.org\/10.1007\/s13346-018-0570-0","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,16]]},"assertion":[{"value":"16 August 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All breeding procedures were approved by the Animal Ethics Committee of the University of South Australia.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Ankit Parikh, Xin-Fu Zhou, and Sanjay Garg are the named inventors of Chinese patent 201610267974.5. Fujian Kangshimei Co., China owns the intellectual property. There is no other potential conflict of interest relevant to this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}